Clarity
Independent understanding of earnings quality, risks, and value drivers, free from sponsor framing.
We operate at the intersection of healthcare operators and capital, advising the builders of practices and the investors who acquire them.
Wherever you sit in the lifecycle of healthcare enterprise, there is a door built for you.
Formation, growth infrastructure, and exit readiness for independently owned practices and emerging groups. Imagine having your own CEO, CFO, and COO infrastructure, without giving up clinical independence.
Explore Founder AdvisoryDedicated advisory for private equity, family offices, and strategic acquirers. Sourcing, underwriting, execution, and value creation across the full investment lifecycle.
Access TAGGrowth and acquisition capital, lending access, and capital structuring through HealthStream Capital, the investment arm of the HSV ecosystem.
Explore Capital OptionsEach side of our practice generates intelligence the other side cannot buy.
Our work with doctor-led groups provides real-time visibility into platform formation, performance, and seller dynamics, informing how we advise institutional capital.
Our work with institutional investors gives us direct insight into what buyers value, allowing us to prepare founder-led groups for premium outcomes before the transaction begins.
Neither pure-play brokers nor generalist consultants can replicate this structural advantage.
Every dental platform moves through the same arc. HSV advises on both sides of it, and the transaction is where the two paths meet.
Founders, groups, and investors who faced the same decisions you face now. The results speak plainly.
Former C-level leadership within large, scaled healthcare organizations
Platforms taken from inception through multi-site expansion
Principal capital invested in dental and healthcare platforms
Exits aligned with institutional return objectives and transaction discipline
Advisory grounded in firsthand execution across the full lifecycle of healthcare platforms, not in diligence models or theoretical frameworks.
The same lifecycle applies in every sector we serve: platforms form, scale, transact, and compound value. Sector economics change; the discipline does not.
View All SectorsWe partner with independently owned practices and emerging groups to build, scale, and manage healthcare platforms designed for long-term growth or a premium transaction.
Every doctor-led platform moves through the same four stages. Our advisory meets you at your stage and builds toward the next one, so the enterprise you build is the enterprise buyers pay a premium for.
Scaling beyond 3 to 5 locations breaks the systems that got you there. Growth demands infrastructure: financial discipline, governance, leadership architecture, and operational systems that hold up under institutional diligence.
Most founders face a false choice between selling early or scaling alone. We built a third path.
A validated financial baseline, a defendable enterprise valuation, and your strategic options modeled to specific outcomes. Know exactly where you stand before you decide anything.
Explore the AssessmentDSO and MSO architecture, governance design, and equity alignment built to withstand diligence from day one, with a formation thesis that scales from your first add-on forward.
Explore Group FormationSell-side representation across every buyer channel, and buy-side support for groups making acquisitions. Diligence, valuation, integration, and capital under one advisor.
Explore M&A AdvisoryExecutive operating leadership without the full-time hire. Systems, accountability, and management cadence that let clinicians lead clinical culture while the enterprise runs with discipline.
Explore COO ServicesStrategic finance leadership for owners serving as the de facto CFO. Forecasting, capital readiness, and enterprise value strategy, not bookkeeping.
Explore CFO Services“Imagine having your own CEO, CFO, and COO infrastructure, without giving up clinical independence.” The HSV Operating Partnership
Make the right decision with complete clarity. Investment-grade financial analysis, a defendable enterprise valuation, and your strategic pathways quantified.
At some stage, every practice owner faces the same questions. Should I sell my practice or group? Should I continue to grow and scale? Should I bring in a partner or transition ownership?
These are high-stakes decisions, and most dentists are forced to navigate them without a complete picture. Your CPA, attorney, and wealth advisor each provide valuable input, but none are built to evaluate your full business, your full value, and your full set of options in one place. The gap is structural, not aspirational: financial reporting is often incomplete, valuation assumptions are untested, and optionality is discussed abstractly rather than modeled with precision.
A validated picture of financial health, profitability, cash flow profile, and capital structure, built from source data, not management summaries.
An objective valuation range supported by market and intrinsic methodologies, with full transparency into the assumptions and adjustments that drive the number.
Quantified, scenario-based strategic alternatives covering organic growth, ownership transition, and platform formation, each modeled to specific financial outcomes.
We do not provide opinions. We provide quantified scenarios, compared side by side.
A complete, decision-ready package designed to withstand institutional diligence.
A standalone synthesis of financial health, enterprise value, and strategic positioning.
Historical and adjusted P&L, balance sheet analysis, cash flow, and provider compensation detail.
A documented walk from reported EBITDA to adjusted EBITDA across every normalization category.
Historical financials, pro forma adjustments, and sensitivity analysis built for institutional presentation.
A triangulated enterprise valuation range with methodologies, assumptions, and market benchmarking.
Quantified pathway comparisons plus a prioritized 12 to 36 month strategic roadmap.
Practices with 1 to 5 locations can typically expect completion within 4 to 6 weeks of kickoff.
For practices positioned to evolve from single-site or small-group operations into scalable platforms. We design the structure first, so the enterprise scales without breaking and transacts without discounting.
DSO and MSO entity design, governance frameworks, and equity alignment built to withstand institutional diligence from day one.
Acquisition criteria, geographic strategy, and underwriting parameters for identifying and evaluating expansion targets.
The operational playbook for post-acquisition integration: systems consolidation, staffing models, compliance frameworks, and brand strategy.
Equity and debt requirements for the build strategy, including leverage tolerance, capital efficiency metrics, and phased deployment tied to acquisition pacing.
We project the consolidated financial profile at defined milestones, typically 3, 5, and 7 locations, and model the valuation multiple expansion that accompanies platform-level scale and infrastructure. The outcome is a structured formation thesis with defined target criteria, capital requirements, an integration playbook, and a projected enterprise value trajectory, designed to attract institutional capital or guide self-funded expansion.
We know what institutional buyers value because we advise them. Your platform is built to that standard from formation, not retrofitted for it at transaction.
Transaction advisory for doctor-led practices and groups, on both sides of the table. We reduce time, risk, and friction in the deal process with a 360-degree view of every transaction, delivered by a team that has owned, operated, and invested in the businesses being bought and sold.
Healthcare M&A is not for the faint-hearted.
Anyone with even the slightest exposure to healthcare M&A will confirm that acquiring medical or dental practices, no matter the scale, is a major undertaking. Process discipline is what separates premium outcomes from expensive lessons, and process discipline is what we bring.
When you are ready to transact, HSV leads the go-to-market across every buyer channel: PE-backed DSOs, regional groups, and doctor-owned platforms. Prepared sellers command premium outcomes, and preparation is what the rest of our advisory builds toward.
For growing groups making add-on acquisitions, a disciplined approach to identifying, acquiring, and integrating the right practices: deal readiness, target screening, diligence, and integration planning that protects the value you are paying for.
An approach unique to the industry among M&A advisory firms. True Diligence evaluates and provides insight on the state of the enterprise across financial and tax, clinical and regulatory, compliance, and operational dimensions.
Effectively and efficiently integrating new assets into your portfolio can determine the lifelong viability and success of the investment. Our team of former DSO operators ensures it succeeds.
Valuation is a complex process requiring a skillful blend of fundamental analysis, industry experience, and sound judgment. HealthStream's valuation team has the expertise to establish a defensible, actionable conclusion.
M&A growth equity and debt, venture and private equity capital raises, and related strategic advisory, so the capital stack serves the acquisition strategy.
Capital raise support for acquisitions, spanning M&A equity, debt, and private capital, is delivered through HealthStream Capital.
The buy-side acquisition process, managed end to end. Engagements can span the full sequence or be scoped to individual stages.
Single locations preparing for a first acquisition, a partnership, or an eventual sale.
Doctor-led groups executing add-on acquisitions and building toward platform scale.
Scaled organizations that need transaction depth without expanding internal deal teams.
Founders approaching a liquidity decision who want the buyer's playbook before going to market.
Healthcare investors and funds pursuing buy-side mandates are served by our dedicated investor practice. Explore TAG Buy-Side Advisory.
Executive operating leadership for growing groups, without the full-time hire. We build the systems, decision paths, and accountability that keep the enterprise moving, so you lead from vision instead of vigilance.
Stakeholder interviews, vendor and contract review, operational systems evaluation, and an audit of current initiatives to isolate what needs attention first.
Team strengths and skill gap analysis, cultural and mission alignment, and role realignment so the right people hold the right seats.
Vision setting with ownership and a goal framework that translates big-picture objectives into measurable targets across administrative, clinical, and operational areas.
Hiring frameworks, retention and career pathing, standardized onboarding, and targeted training across the full patient journey.
KPI development tailored to your goals, real-time dashboards and reporting, and a continuous improvement culture aligned around quantifiable outcomes.
A unified operational framework to centralize and scale operations, weekly management cadence, change management, and hands-on implementation support as the group evolves.
Scalable processes, standardized reporting, and shared service models that improve productivity and lower costs.
Role realignment and a refined talent strategy ensure the right people are in the right positions, driving performance and engagement.
A systematic operational framework and cohesive leadership team position the group for acquisitions, funding, and strategic transitions.
Strategic finance leadership for growth-minded healthcare operators. CFO-level direction without the full-time overhead, delivered by a team that has led the budgets, raised the capital, and grown the groups.
In most privately held dental and medical businesses, the owner serves as the de facto CFO, without the time, training, or tools to lead a high-performing finance function.
We step in as fractional or interim CFOs, delivering strategic guidance, financial insight, and execution capacity to unlock enterprise value. We are not bookkeepers; we are your strategic finance partner. Our work is most effective when your internal team manages day-to-day accounting, freeing us to focus on analysis, decision-making, capital readiness, and growth strategy.
Comprehensive financial review, KPI dashboards and industry benchmarking, proactive budget and forecasting cycles, and profitability enhancement initiatives.
Industry positioning, compliance and operational risk assessment, debt and capital structure review, liquidity and contract stability, and M&A exposure review.
Scenario-based, stress-tested cash forecasting covering payroll, hiring timelines, capital investment, and growth-stage funding, aligned with strategic priorities.
Long-range financial roadmaps, support for capital raises and lender negotiations, and planning for succession, ESOPs, and incentive structures.
Engagement models include fixed-fee pricing scoped to defined deliverables, hourly advisory, performance-based billing tied to revenue or activity metrics, and structures aligned to value growth identified. We continuously reassess your finance needs so the function scales with the business.
Strategic advisory for healthcare investors, from private equity firms and family offices to independent sponsors and strategic acquirers, entering, expanding, and scaling investments in dental and multi-site healthcare markets.
TAG is HealthStream Ventures' dedicated advisory division for healthcare investors deploying capital into platform acquisitions. Unlike traditional intermediaries, TAG operates as a strategic partner to capital: aligned with investor outcomes across the full investment lifecycle, from opportunity identification through exit positioning.
Since 2021, TAG has partnered with healthcare investors not only to underwrite and execute transactions, but to identify investment opportunities, develop acquisition pipelines, and build scalable platform strategies, particularly for investors entering the space for the first time or seeking to expand beyond their current capabilities.
We help healthcare investors identify the right opportunities, structure transactions defensibly, build platforms that scale, and unlock enterprise value through disciplined, execution-driven operations.
Target sourcing, pipeline development, and acquisition prioritization aligned with strategy, geography, and return profile.
First-investment advisory including platform selection, risk calibration, and structuring the initial transaction to scale rather than simply close.
Independent thesis validation, EBITDA normalization, valuation modeling, and IC decision support free from sponsor framing.
Deal structuring, LOI development, negotiation strategy, IC materials, and cross-party coordination through closing.
100-Day Plans, EBITDA optimization, add-on roll-up strategy, and governance implementation across PE-backed platforms.
We have operated the businesses our clients are acquiring. Built the platforms they are trying to scale. Invested as principals. Underwritten and executed the strategies they are evaluating. And exited platforms aligned with institutional return objectives.
Our advisory is grounded in what actually works in practice, not in diligence models or theoretical frameworks.
Why HealthStreamTAG supports PE-backed dental and healthcare platforms through EBITDA realization, integration of add-on acquisitions, governance maturation, and the operational infrastructure required to scale beyond a firm's internal capabilities.
Independent understanding of earnings quality, risks, and value drivers, free from sponsor framing.
Defensible underwriting and investment rationale that withstands IC scrutiny.
Structured execution discipline and realized post-close value tied to EBITDA and enterprise value.
A unified advisory model spanning opportunity identification through post-close value creation. Engagements can span the full lifecycle or be scoped to a single phase.
TAG sources, refines, and prioritizes acquisition opportunities aligned with each investor's strategy, geographic focus, and return profile.
For investors making their first investment in dental or healthcare services, TAG provides structured guidance on platform selection, ensuring the initial transaction is built to scale, not simply priced to close.
TAG provides independent, investor-defensible underwriting that translates diligence into actionable investment insight.
TAG serves as an embedded transaction advisor, providing continuous support from LOI through closing.
TAG develops and executes value creation strategies that translate into realized enterprise value, not theoretical projections.
Embedded buy-side advisory for private equity groups and PE-backed DSOs and MSOs identifying and acquiring dental and multi-site healthcare assets. We function as an extension of your deal team, from thesis definition through closing, with underwriting grounded in operating reality.
Most buy-side processes fail before diligence begins: the thesis is imprecise, the pipeline is auction-dependent, and the underwriting accepts sponsor framing at face value.
TAG leads capital through both halves of the problem. On the identification side, disciplined criteria, proprietary sourcing, and target scoring calibrated to your return profile. On the acquisition side, operator-grade underwriting, EBITDA validation, structuring, and negotiation through close. Advisory is non-contingent and aligned with investment outcomes, not transaction completion.
For funds entering healthcare or acquiring their next platform: entry strategy, platform selection, independent thesis validation, IC-ready underwriting, and execution through close. The initial transaction is structured to scale, not simply priced to close.
For platforms executing buy-and-build: an outsourced M&A and development function that sustains pipeline velocity, applies repeatable underwriting standards to every target, and delivers integration-ready closings at program pace.
A defined sequence from mandate to close. Each stage produces work product your Investment Committee can act on.
Independent recommendation: proceed, renegotiate, defer, or exit.
Base, upside, and downside cases with the assumptions exposed.
Current state to achievable state, documented adjustment by adjustment.
Clinical, regulatory, financial, and operational exposures with structuring responses.
Counterparty positioning, term recommendations, and leverage points.
Managed coordination across what can be 100 touch points to close.
The structural edge: our advisory work with doctor-led groups gives us ground-level insight into how sellers think, what motivates them, and where reported earnings diverge from run-rate reality. Your underwriting reflects it.
What differentiates HealthStream is not a consulting methodology or an analytical framework. It is direct, real-world experience across the full lifecycle of healthcare platforms, from inception through exit.
Former C-level leadership within large, scaled healthcare organizations. We have run the businesses our clients are acquiring.
Platforms from inception through multi-site expansion. We understand the operational complexity of building a platform, not just inheriting one.
In dental and healthcare platforms as principals, not just as advisors. Our perspective is grounded in capital deployment, not consulting.
The underwriting, acquisition, integration, and growth strategies our clients are evaluating. We have done the work, not just modeled it.
Platforms aligned with institutional return objectives and transaction discipline. We understand what it takes to position and sell.
This experience positions TAG to advise with authority across four critical areas:
Clinical operations, staffing models, patient flow, site-level performance optimization.
Revenue cycle, cost structure analysis, earnings normalization, margin expansion strategy.
Scalable systems, governance architecture, compliance frameworks, institutional readiness.
Execution-driven strategies that translate into realized enterprise value.
Structured around the investment lifecycle with defined phases and deliverables at each stage. Engagements can span the full lifecycle or be scoped to individual phases based on the capital partner's requirements. TAG operates as an extension of the investment team, not a separate workstream.
What healthcare investors gain from a TAG engagement.
A true, independent understanding of earnings quality, risks, market positioning, and value drivers, free from sponsor framing. TAG provides the analytical foundation for informed capital deployment decisions.
Defensible underwriting, validated investment theses, and IC-ready rationale grounded in operational reality. Every recommendation withstands institutional scrutiny because it is built on firsthand platform experience.
Structured execution discipline and realized post-close value. Clear pathways from initial acquisition through platform scaling and exit positioning, with enterprise value as the constant measure.
Platform identification, buy-side diligence, underwriting support, value creation planning, and add-on roll-up strategy.
First-investment entry strategy, thesis validation, operational assessment, and transaction structuring for direct healthcare investments.
Sector entry advisory, opportunity screening, independent underwriting, and platform strategy for funds expanding into healthcare direct investments.
Acquisition pipeline development, target diligence, integration-ready deal structuring, and platform expansion strategy.
Deal sourcing, underwriting support, capital raise positioning, and full-lifecycle transaction advisory for fundless sponsor models.
Investment thesis development, platform identification, and institutional-grade diligence to support capital formation and deployment.
TAG operates not as a traditional intermediary, but as an extension of the investment team: grounded in operator experience, aligned with investor outcomes, and focused on building platforms that scale, transact, and endure.
HealthStream Capital deploys and structures capital for dental and multi-site healthcare enterprises, investing alongside the operators, platforms, and trusted leadership of the HSV ecosystem. The same principals behind 300+ dental transactions and 20+ platform formations stand behind every capital decision.
Explore Capital Options↗We start with your enterprise, not a term sheet: growth plans, acquisition pipeline, ownership objectives, and the role capital plays in reaching them. Alignment precedes structure.
We design the debt and equity mix around your objectives: growth capital, acquisition financing, or a blended structure, engineered to protect enterprise value and ownership economics.
The transaction executes through HealthStream Capital's independent platform, with the HSV ecosystem's operating discipline carried through deployment, integration, and scale.
Visit the dedicated HealthStream Capital platform to view active investment criteria or submit an intake inquiry. The button below opens healthstream.capital in a new tab, so you keep your place here.
Continue to HealthStream Capital↗Funding for expansion, add-on acquisitions, and de novo development across the platform lifecycle, structured to the stage the enterprise is actually at.
Direct investments in dental and multi-site healthcare platforms, made alongside founders and institutional partners with aligned economics.
Debt and equity structuring, lender access, and capital stack design engineered to protect enterprise value through growth and transaction.
Co-investment and partnership structures that align operators, capital, and the HSV advisory ecosystem around the same outcome.
HealthStream Capital is a separate legal entity from HealthStream Ventures, LLC. The two firms share common principals and operate as an integrated ecosystem. Nothing on this page constitutes an offer to sell or a solicitation of an offer to buy any security.
We advise multi-site provider services platforms across eight sectors. The clinical models differ; the enterprise mechanics do not. In every sector, we serve the founders building platforms and the capital acquiring them, applying the same lifecycle discipline from formation through exit.
Our founding sector and deepest bench. From single-doctor practices to multi-region DSOs, we have formed, operated, invested in, and transacted dental platforms across every stage of the consolidation cycle. DSO consolidation remains in its middle innings, and the spread between well-structured and poorly structured platforms continues to widen. That spread is where we work.
Accelerating demand and expanding payer support meet deep fragmentation and workforce constraints. Platform outcomes in behavioral health are decided by clinical governance, workforce architecture, and reimbursement discipline, not by acquisition pace.
Chronic disease prevalence is driving durable demand while consolidation remains early. We advise on platform formation and entry strategy in a specialty where access, infrastructure, and ancillary integration create enterprise value.
A consumer-driven, largely cash-pay market maturing from concept into enterprise. We help founders and investors underwrite what endures: unit economics, clinical credibility, and operating models that repeat across sites.
Consolidation continues across physician specialties, and growth alone no longer differentiates. We advise PPM platforms on integration, provider alignment, payer complexity, and the infrastructure that supports capital events.
High consumer demand and low institutional penetration make aesthetics one of the most active formation markets in provider services. Value accrues to platforms that professionalize operations, compliance, and provider economics early.
Surgeon-led economics with durable demand across aesthetic and reconstructive lines. We structure platforms that respect clinical autonomy while building the operating leverage a transaction requires.
A broad care continuum with sustained institutional interest, from OB/GYN and fertility through menopause care. We advise founders and capital on platform structures that scale access while protecting clinical quality.
The lifecycle framework travels. If your platform or thesis sits adjacent to these sectors, the conversation is worth having. Enterprise mechanics transfer; we underwrite the clinical model case by case.
HealthStream Ventures combines investment banking rigor, legal architecture, operational DSO experience, and principal investment experience under one roof. We advise the builders of practices and the investors who acquire them.
Advisory informed by firsthand executive leadership within large, scaled healthcare organizations.
Proven experience building platforms from inception through scale, not inherited or acquired platforms.
Perspectives grounded in direct capital deployment experience in dental and healthcare platforms.
A track record of exits aligned with institutional investor return objectives and transaction discipline.
Tell us who you are and we will route you to the right team. Every inquiry is reviewed by a partner.
Routed to Founder Advisory. A partner from the operator practice will follow up.